Correlation Between Dyadic International and Monopar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dyadic International and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and Monopar Therapeutics, you can compare the effects of market volatilities on Dyadic International and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and Monopar Therapeutics.
Diversification Opportunities for Dyadic International and Monopar Therapeutics
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Dyadic and Monopar is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Dyadic International i.e., Dyadic International and Monopar Therapeutics go up and down completely randomly.
Pair Corralation between Dyadic International and Monopar Therapeutics
Given the investment horizon of 90 days Dyadic International is expected to generate 1.11 times more return on investment than Monopar Therapeutics. However, Dyadic International is 1.11 times more volatile than Monopar Therapeutics. It trades about 0.43 of its potential returns per unit of risk. Monopar Therapeutics is currently generating about 0.09 per unit of risk. If you would invest 109.00 in Dyadic International on August 28, 2024 and sell it today you would earn a total of 82.00 from holding Dyadic International or generate 75.23% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dyadic International vs. Monopar Therapeutics
Performance |
| Timeline |
| Dyadic International |
| Monopar Therapeutics |
Dyadic International and Monopar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dyadic International and Monopar Therapeutics
The main advantage of trading using opposite Dyadic International and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.| Dyadic International vs. Werewolf Therapeutics | Dyadic International vs. Edgewise Therapeutics | Dyadic International vs. Celcuity LLC | Dyadic International vs. C4 Therapeutics |
| Monopar Therapeutics vs. Eliem Therapeutics | Monopar Therapeutics vs. HCW Biologics | Monopar Therapeutics vs. Scpharmaceuticals | Monopar Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |